Differentiation of High-Grade and Low-Grade Gliomas Using Pattern Analysis of Long-Echo Single-Voxel Proton Magnetic Resonance Spectroscopy (H-MRS)

Chernov, M. F.; Ono, Y.; Muragaki, Y.; Kubo, O.; Nakamura, R.; Iseki, H.; Hori, T.; Takakura, K.
June 2008
Neuroradiology Journal;Jun2008, Vol. 21 Issue 3, p338
Academic Journal
The usefulness of proton magnetic resonance spectroscopy (¹H-MRS) for glioma grading is not clear, particularly due to the absence of standard criteria for data analysis. Previously we had developed an original classification of the pathological 1H-MR spectra based on the identification of the predominant metabolite peak, N-acetylaspartate (NAA) for Type I, choline-containing compounds (Cho) for Type II, and mobile lipids (Lip) for Type III, and presence or absence of other metabolite peaks: lactate (Lac), Lip, or Cho. The present study evaluated the effectiveness of this classification in grading of previously non-treated gliomas. A total of 38 low-grade and 33 high-grade neoplasms were investigated. Four tumors had 1H-MR spectra Type I, and all of those were low-grade. Three tumors had 1H-MR spectra Type III, and all those were glioblastomas. Fifteen tumors with 1H-MR spectra Type II had a Lip/NAA ratio more than 1 (Type II C with moderate elevation of lipids), and 12 of those neoplasms were high-grade. The differences in distribution of high-grade and low-grade gliomas among another 49 gliomas with 1H-MR spectra Type II did not depend on the presence of Lac and/or Lip peaks, and in this subgroup NAA/Cho ratio was also evaluated. Inclusion of both characteristics (type of the 1H-MR spectrum and NAA/Cho ratio with defined cut-off level of 0.6) into the diagnostic algorithm yielded 72% diagnostic accuracy (95% confidence interval: 62%-82%) in discriminating high-grade and low-grade neoplasms. In conclusion, pattern analysis of the pathological 1H-MR spectra using the proposed classification along with evaluation of NAA/Cho ratio might be helpful for non-invasive glioma grading.


Related Articles

  • Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. Qing-Shi Zeng; Chuan-Fu Li; Kai Zhang; Hong Liu; Xiao-Shui Kang; Jun-Hui Zhen // Journal of Neuro-Oncology;Aug2007, Vol. 84 Issue 1, p63 

    Abstract Objective  To explore the usefulness of multivoxel 3D proton MR spectroscopy (1H-MRS) in assessing the recurrent contrast-enhancing areas at the site of the previously treated gliomas. Materials and methods  In 28 patients who had new...

  • Should a child with neurofibromatosis type 1 be screened for central nervous system tumours with neuroimaging? Bodey, Caroline; Seal, Arnab // Archives of Disease in Childhood;Jun2014, Vol. 99 Issue 6, p595 

    The article presents a case study of a four-year-old boy who was diagnosed with neurofibromatosis type 1 (NF1) disease and discusses the need for the screening of optic pathway gliomas (OPG) with magnetic resonance imaging (MRI). Topics discussed include complications associated with brain...

  • Diagnostic value of the fast-FLAIR sequence in MR imaging of intracranial tumors. Husstedt, H. W.; Sickert, M.; Köstler, H.; Haubitz, B.; Becker, H. // European Radiology;May2000, Vol. 10 Issue 5, p745 

    The aim of this study was to quantify imaging characteristics of fast fluid-attenuated inversion recovery (FLAIR) sequence in brain tumors compared with T1-postcontrast- and T2-sequences. Fast-FLAIR-, T2 fast spin echo (FSE)-, and T1 SE postcontrast images of 74 patients with intracranial...

  • Differentiation of benign and malignant uterine corpus tumors by using proton MR spectroscopy at 3T: preliminary study. Takeuchi, Mayumi; Matsuzaki, Kenji; Harada, Masafumi // European Radiology;Apr2011, Vol. 21 Issue 4, p850 

    Objective: To retrospectively evaluate the diagnostic ability of magnetic resonance (MR) spectroscopy for distinguishing benign and malignant lesions in patients with uterine corpus tumours at MR imaging. Methods: Pelvic MR spectroscopy was performed in patients with pathologically diagnosed...

  • Prognostic Significance of Serial Magnetic Resonance Spectroscopies over the Course of Radiation Therapy for Patients with Malignant Glioma. Alexander, A.; Murtha, A.; Abdulkarim, B.; Mehta, V.; Wheatley, M.; Murray, B.; Riauka, T.; Hanson, J.; Fulton, D.; Urtasun, R.; McEwan, A.; Roa, W. // Clinical & Investigative Medicine;Oct2006, Vol. 29 Issue 5, p301 

    Background: The standard treatment of high grade gliomas (HGG) involves maximal neuro-surgical debulking, followed by post-operative radiotherapy, with or without concurrent chemotherapy, depending on histologic grade. Despite this aggressive strategy, there are few long-term survivors....

  • Magnetic Resonance Imaging and Localized In Vivo Proton Spectroscopy in Patients with Fulminant Hepatic Failure. Gupta, R. K.; Saraswat, V. A.; Poptani, H.; Dhiman, R. K.; Kohli, A.; Gujral, R. B.; Naik, S. R. // American Journal of Gastroenterology;May1993, Vol. 88 Issue 5, p670 

    Magnetic resonance imaging (MRI) and in vivo proton spectroscopic changes in the brain in three patients with fulminant hepatic failure are described. MRI showed cerebral atrophy in two and changes somewhat similar to what have been described in chronic hepatic encephalopathy. MR spectroscopy...

  • Functional assessment of skeletal muscle in intact mice lacking myostatin by concurrent NMR imaging and spectroscopy. Baligand, C.; Gilson, H.; Ménard, J. C.; Schakman, O.; Wary, C.; Thissen, J.-P.; Carlier, P. G. // Gene Therapy;Mar2010, Vol. 17 Issue 3, p328 

    Inhibiting myostatin (mstn) causes spectacular increase in muscle mass, spurring research for therapeutic approaches against neuromuscular disorders. Yet, possible functional deterioration and compromised force production have been reported in isolated muscle of null mstn(−/−) mice....

  • X-Linked Creatine Transporter Deficiency Presenting as a Mitochondrial Disorder. Hathaway, Samantha C.; Friez, Michael; Limbo, Kimberly; Parker, Colette; Salomons, Gajja S.; Vockley, Jerry; Wood, Tim; Abdul-Rahman, Omar A. // Journal of Child Neurology;Aug2010, Vol. 25 Issue 8, p1009 

    X-linked creatine transporter defect is caused by mutations in SLC6A8 at Xq28, which encodes the sodium-dependent creatine transporter. Reduction in creatine uptake results in elevated urine creatine and CSF creatine deficiency, which can be detected on magnetic resonance spectroscopy. We report...

  • Megalencephalic leukoencephalopathy with subcortical cysts in an adult: quantitative proton MR spectroscopy and diffusion tensor MRI. Brockmann, K.; Finsterbusch, J.; Terwey, B.; Frahm, J.; Hanefeld, F. // Neuroradiology;Mar2003, Vol. 45 Issue 3, p137 

    A 37-year-old macrocephalic woman was investigated for increasing gait disturbance due to longstanding spasticity and ataxia. MRI showed widespread bilateral increase in signal from cerebral white matter on T2-weighted images. Numerous subcortical cysts were visible in anterior-temporal and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics